Studies finding that cannabis, or marijuana as it is more commonly known, has both a mitigating and prophylactic effect with regards to Alzheimer’s disease continue to accumulate. One of the latest articles comes from researchers working at the Department of Physiology and Trinity College Institute of Neuroscience, Trinity College Dublin. They found that “certain cannabinoids can protect neurons from the deleterious effects of β-amyloid and are capable of reducing tau phosphorylation. The propensity of cannabinoids to reduce β-amyloid-evoked oxidative stress and neurodegeneration, whilst stimulating neurotrophin expression neurogenesis, are interesting properties that may be beneficial in the treatment of Alzheimer's disease” and the Scientists concluded that “cannabinoids offer a multi-faceted approach for the treatment of Alzheimer's disease by providing neuroprotection and reducing neuroinflammation, whilst simultaneously supporting the brain's intrinsic repair mechanisms by augmenting neurotrophin expression and enhancing neurogenesis.”

Cross posted on The Trebach Report

Hat tip to Ian Goddard